Alzheimer’s drug trial explores gut-brain link

With new avenues of research exploring the link between the gut and the brain, an innovative Alzheimer’s drug from China offers clues.

Produced by Email Bluesky Facebook LinkedIn Reddit Whatsapp X Download PDF Meiyu Geng (seated) and the research team at Green Valley Research Institute. Credit: Shanghai Green Valley Pharmaceutical Co., Ltd Dementia affects around 50 million people with 10 million new cases annually, more than half due to Alzheimer’s disease. While patient numbers are expected to triple by 2050, few therapeutic strategies have shown promise to date. With new studies hinting at a more complex story, Meiyu Geng, a professor of pharmacology at the Shanghai Institute of Materia Medica Chinese Academy of Sciences (

related reading

• Glial Cells Play Key Role in Alzheimer's Development - Neuroscience Newsneurosciencenews.com
• It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough | Jonathan Schott | The Guardiantheguardian.com
• Gap Mapgap-map.org
• Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
• Contrary Research on X: "The Virtual Cell Revolution" / Xx.com
• FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease | FDAfda.gov
• Sonja W. Scholz, M.D., Ph.D. | Principal Investigators | NIH Intramural Research Programirp.nih.gov
• Nintil - The failure of monoclonal antibody therapy for Alzheimer's Disease, implications for the Amyloid Cascade Hypothesisnintil.com
• Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
• Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
• Synapse formation in the brain can be enhanced by co-administering three specific nutrients - PubMedpubmed.ncbi.nlm.nih.gov
• Our body is a mosaic of fungi. Some scientists think they could be influencing our brainbbc.com